(19)
(11) EP 1 303 262 A2

(12)

(88) Date of publication A3:
06.09.2002

(43) Date of publication:
23.04.2003 Bulletin 2003/17

(21) Application number: 01952123.6

(22) Date of filing: 29.06.2001
(51) International Patent Classification (IPC)7: A61K 31/00, A61K 31/404, A61K 31/5377, A61K 31/403, A61K 45/06, A61P 31/02
(86) International application number:
PCT/US0116/509
(87) International publication number:
WO 0200/5796 (24.01.2002 Gazette 2002/04)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 14.07.2000 US 218928 P
18.12.2000 US 256398 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, IN 46285 (US)

(72) Inventors:
  • LOH, Andrew
    Carmel, IN 46033 (US)
  • MACIAS, William, Louis
    Indianapolis, IN 46234 (US)
  • SKERJANEC, Simona
    Pittstown, NJ 08867 (US)

(74) Representative: Kingsbury, Oliver William 
Eli Lilly and Company Limited,Erl Wood Manor,Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) USE OF A SPLA2 INHIBITOR FOR THE TREATMENT OF SEPSIS